Current Understanding of Atrophic Gastritis and Intestinal Metaplasia as a Premalignant Lesion of Gastric Cancer

Gastric cancer is the fifth most common and third leading cause of cancer death worldwide. Patients with chronic atrophic gastritis (CAG) and intestinal metaplasia (IM) are at increased risk of developing gastric cancer (GC). It is common for CAG to precede IM, but the etiology of the two conditions...

Full description

Saved in:
Bibliographic Details
Main Author: Zornitsa Gorcheva
Format: Article
Language:English
Published: Medical University - Pleven 2022-11-01
Series:Journal of Biomedical & Clinical Research
Subjects:
Online Access:https://jbcr.arphahub.com/article/34643/download/pdf/
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849406735087828992
author Zornitsa Gorcheva
author_facet Zornitsa Gorcheva
author_sort Zornitsa Gorcheva
collection DOAJ
description Gastric cancer is the fifth most common and third leading cause of cancer death worldwide. Patients with chronic atrophic gastritis (CAG) and intestinal metaplasia (IM) are at increased risk of developing gastric cancer (GC). It is common for CAG to precede IM, but the etiology of the two conditions is not always the same. Different scoring systems are used to assess HAG, MI, and GC risk, making it difficult to interpret results from investigations and management of these conditions.
format Article
id doaj-art-6ef6e8be5c534c68a86eb430139819a4
institution Kabale University
issn 1313-9053
language English
publishDate 2022-11-01
publisher Medical University - Pleven
record_format Article
series Journal of Biomedical & Clinical Research
spelling doaj-art-6ef6e8be5c534c68a86eb430139819a42025-08-20T03:36:18ZengMedical University - PlevenJournal of Biomedical & Clinical Research1313-90532022-11-0115211812210.2478/jbcr-2022-001634643Current Understanding of Atrophic Gastritis and Intestinal Metaplasia as a Premalignant Lesion of Gastric CancerZornitsa GorchevaGastric cancer is the fifth most common and third leading cause of cancer death worldwide. Patients with chronic atrophic gastritis (CAG) and intestinal metaplasia (IM) are at increased risk of developing gastric cancer (GC). It is common for CAG to precede IM, but the etiology of the two conditions is not always the same. Different scoring systems are used to assess HAG, MI, and GC risk, making it difficult to interpret results from investigations and management of these conditions.https://jbcr.arphahub.com/article/34643/download/pdf/chronic atrophic gastritisintestinal metaplasia
spellingShingle Zornitsa Gorcheva
Current Understanding of Atrophic Gastritis and Intestinal Metaplasia as a Premalignant Lesion of Gastric Cancer
Journal of Biomedical & Clinical Research
chronic atrophic gastritis
intestinal metaplasia
title Current Understanding of Atrophic Gastritis and Intestinal Metaplasia as a Premalignant Lesion of Gastric Cancer
title_full Current Understanding of Atrophic Gastritis and Intestinal Metaplasia as a Premalignant Lesion of Gastric Cancer
title_fullStr Current Understanding of Atrophic Gastritis and Intestinal Metaplasia as a Premalignant Lesion of Gastric Cancer
title_full_unstemmed Current Understanding of Atrophic Gastritis and Intestinal Metaplasia as a Premalignant Lesion of Gastric Cancer
title_short Current Understanding of Atrophic Gastritis and Intestinal Metaplasia as a Premalignant Lesion of Gastric Cancer
title_sort current understanding of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancer
topic chronic atrophic gastritis
intestinal metaplasia
url https://jbcr.arphahub.com/article/34643/download/pdf/
work_keys_str_mv AT zornitsagorcheva currentunderstandingofatrophicgastritisandintestinalmetaplasiaasapremalignantlesionofgastriccancer